Filter

1 - 10 of 440 Results

  • Abortion Trends Before and After Dobbs

    Issue Brief

    This brief reviews the different sources of abortion data in the United States, the factors that have affected abortion rates across the U.S, before and after Roe v. Wade, and what we may see as the Trump administration, Republican majorities in the House and Senate, and a conservative federal judiciary shape policy in the coming years.

  • Key Facts on Abortion in the United States

    Issue Brief

    This issue brief answers some key questions about abortion in the United States and presents data collected before and new data that has been published since the overturn of Roe v. Wade.

  • KFF Health Tracking Poll: Knowledge and Views of Medication Abortion

    Poll Finding

    This KFF Health Tracking Poll finds that many, including women of reproductive age, remain unfamiliar with key facts about mifepristone. Fewer than half of all adults say they believe abortion pills are safe now, compared to over half of all adults two years ago. This poll explores awareness and perception of the recent FDA review of the medication, and support for policies aimed at restricting it.

  • State Variations in the Role of the Reproductive Health Safety Net for Contraceptive Care Among Medicaid Enrollees

    Issue Brief

    This KFF analysis uses 2023 T-MSIS Research Identifiable Files to look at where reproductive-age female Medicaid enrollees received their last contraceptive visit by state. Overall, more than four in 10 (43%) female Medicaid enrollees received their last contraceptive visit of 2023 at a safety net provider, which includes Planned Parenthood clinics, community health centers, state and local health departments, and Indian health services, but there is wide variation by state.

  • Policy Landscape of Private Insurance Coverage of Contraception in the U.S.

    Issue Brief

    This issue brief explains the rules for private insurance coverage of contraceptives at the federal and state level, the exemptions and accommodations available for certain employers, gaps in coverage for contraceptives obtained outside of the traditional clinical setting, and how changes in the agencies responsible for making contraceptive recommendations may affect coverage for contraceptives.

  • Will Trump’s Announcement Expand Access to IVF? 

    Policy Watch

    The White House announcement focused on reducing the cost of some IVF drugs and clarifying options for employers to offer standalone fertility benefits for their employees and their dependents. This policy watch examines some key takeaways about the Trump IVF plan.